(Q38817024)

6 September 2017

title

Treating Addictions: Harm Reduction in Clinical Care and Prevention (English)

1 reference

6 September 2017

1 reference

8

Ingrid van Beek

0 references

author name string

Ernest Drucker

1

1 reference

6 September 2017

Kenneth Anderson

2

1 reference

6 September 2017

Robert Haemmig

3

1 reference

6 September 2017

Robert Heimer

4

1 reference

6 September 2017

Dan Small

5

1 reference

6 September 2017

Alex Walley

6

1 reference

6 September 2017

Evan Wood

7

1 reference

6 September 2017

Ingrid van Beek

8

1 reference

6 September 2017

publication date

26 April 2016

1 reference

Journal of Bioethical Inquiry

6 September 2017

published in

1 reference

6 September 2017

volume

13

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

239-249

1 reference

Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Release from prison--a high risk of death for former inmates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Heroin-assisted treatment in the Netherlands: History, findings, and international context

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Overdose prevention and naloxone prescription for opioid users in San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Why buprenorphine is so successful in treating opiate addiction in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation Strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Pharmaceutical overdose deaths, United States, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Evaluation of a naloxone distribution and administration program in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Mortality and HIV transmission among male Vietnamese injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Opioid overdose prevention with intranasal naloxone among people who take methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11673-016-9720-6

Community-based opioid overdose prevention programs providing naloxone - United States, 2010.

21 January 2018

1 reference

12 December 2020

Prescription drug abuse and DEA-sanctioned drug take-back events: characteristics and outcomes in rural Appalachia

1 reference

12 December 2020

The distribution of naloxone to heroin users

1 reference

12 December 2020

Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose

1 reference

12 December 2020

10.1007/S11673-016-9720-6

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1010762882

0 references

1 reference